SCHEMBL4084519

SCHEMBL4084519

CC1(C)c2cc(Nc3ccccc3-c3cccc4ccccc34)ccc2-c2ccc(Nc3ccccc3-c3cccc4ccccc34)cc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FADS1 O60427 1/20 0.42
▸ CDC25B P30305 3/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ TP53 P04637 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ MAPK14 Q16539 2/20 0.37
▸ MAPT P10636 2/20 0.36
▸ PDK2 Q15119 2/20 0.35
▸ STK10 O94804 2/20 0.34
▸ SLK Q9H2G2 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ GLA P06280 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19089973 0.97 FADS1 (0.40) FADS1CDC25BALDH1A1TP53CYP3A4
SCHEMBL231250 0.90 CDC25B (0.53) FADS1CDC25BALDH1A1TP53CYP3A4
SCHEMBL24890009 0.89 FADS1 (0.40) FADS1CDC25BALDH1A1TP53CYP3A4
SCHEMBL12249879 0.89 FADS1 (0.49) FADS1CDC25BALDH1A1TP53CYP3A4
SCHEMBL29514742 0.89 FADS1 (0.49) FADS1CDC25BALDH1A1TP53CYP3A4
SCHEMBL13907827 0.86 FADS1 (0.47) FADS1CDC25BALDH1A1TP53CYP3A4
SCHEMBL25124813 0.86 CDC25B (0.39) FADS1CDC25BALDH1A1TP53CYP3A4
SCHEMBL17733224 0.85 CDC25B (0.39) FADS1CDC25BALDH1A1TP53CYP3A4
SCHEMBL25124788 0.84 CDC25B (0.38) FADS1CDC25BALDH1A1TP53CYP3A4
SCHEMBL22517374 0.84 ALDH1A1 (0.37) FADS1CDC25BALDH1A1TP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2006278-B2 BENZOFLUORENE COMPOUND AND USE THEREOF TOSOH CORP (JP) 2016-10-12 — — EP disclosed
US-8993805-B2 Benzofluorene compound and use thereof TOSOH CORPORATION (JP) 2015-03-31 — — US disclosed
EP-2006278-B1 BENZOFLUORENE COMPOUND AND USE THEREOF TOSOH CORP (JP) 2012-12-26 — — EP disclosed
EP-2006278-A9 BENZOFLUORENE COMPOUND AND USE THEREOF Tosoh Corporation (JP) 2009-08-05 — — EP disclosed
US-20090184312-A1 BENZOFLUORENE COMPOUND AND USE THEREOF TOSOH CORPORATION (JP) 2009-07-23 — — US disclosed
EP-2006278-A2 BENZOFLUORENE COMPOUND AND USE THEREOF Tosoh Corporation (JP) 2008-12-24 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090184312-A1 BENZOFLUORENE COMPOUND AND USE THEREOF SLC7A1, SLC43A1, SLC7A5 FADS1 3090/4885CDC25B 4176/4885ALDH1A1 1932/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback